Roche posts record FY net but shares fall on profit-taking
529990
Swiss pharmaceutical giant Roche has posted a record full year net profit of 9.2 billion Swiss francs (7.4 billion dollars, 5.7 billion euros) in 2006, but its shares fell in morning trading as investors opted for profit-taking.
64070
The drug maker said its fourth-quarter profit fell 70 percent from a year-ago period that included the sale of its consumer health business, but adjusted profit topped Wall Street expectations.
70826
(Corrects second paragraph to show earnings of $17,000, not $28,000)     NEW YORK  - Apparel retailer Talbots Inc.  said on Wednesday that quarterly net profit fell, hurt by heavy markdowns and declining sales at its flagship Talbots chain.
410676
Swiss pharmaceutical giant Novartis on Thursday announced record earnings over the first nine months of the year, but third quarter profits fell 12 percent on sharper competition from generic drugs.
545098
Swiss pharmaceutical giant Roche reported Wednesday a better-than-expected 2007 net profit of 11.4 billion Swiss francs (10.4 billion dollars, 7.1 billion euros), boosted by cancer drug sales.
265367
Allergan Inc. AGN.N on Monday posted  a quarterly profit on growing sales of eye medicines and its  Botox anti-wrinkle product, but warned that 2005 earnings will  fall short of Wall Street expectations.
153503
Swiss drugmaker Novartis AG   missed forecasts with a 42 percent drop in  fourth-quarter net profit, hit by generic competition and a  one-off restructuring charge, sending its shares lower.
283402
BASEL, Switzerland  - Profits at Roche Holding AG leapt 34 percent in 2006 on strong sales of cancer treatments Herceptin and Avastin and flu drug Tamiflu but worries over future margins hit the stock on Wednesday.
652121
Pharmaceutical wholesaler McKesson Corp  reported on Thursday that its quarterly profit fell 17 percent as results were hit by charges and lower profit margins on generic drugs.
49609
Cosmetics maker Estee Lauder Cos. Inc.   posted a lower quarterly profit on Wednesday, dragged  down by a restructuring charge and a settlement with the U.S.  Internal Revenue Service.
515061
Amgen Inc. AMGN.O, the world's  biggest biotechnology company, on Wednesday said quarterly net  profit fell on acquisition charges, but adjusted earnings rose  21 percent on strong sales of its drugs for anemia and  arthritis.
302408
Swiss drugmaker Roche beat forecasts  with a 37 percent rise in first-half net income to 4.543  billion Swiss francs ($3.62 billion), boosted by bumper growth  in its cancer drugs.
15160
The Swiss pharmaceutical company Roche Holding said its chief executive would step down next March as the company separates that job from the chairmanâs position. Franz B. Humer, who has been chief since 1998, will remain chairman of the board. Next July, he also will become chairman of the beverage company Diageo. He will be succeeded by Severin Schwan, 40, who had been the head of Rocheâs diagnostics unit since January. The company also posted a 24 percent increase in first-half net profit, to 4.92 billion Swiss francs ($4.1 billion) from 3.97 billion francs in the period a year earlier. Roche benefited from its flu treatment Tamiflu as governments stockpile the drug in case of an influenza pandemic.
63004
Pharmaceutical wholesaler McKesson Corp  reported on Thursday that its quarterly profit fell 17 percent as results were hurt by lower profit margins on certain generic drugs and charges taken.
535789
Net profit at Roche Holding  AG  rose 34 percent to 9.17 billion Swiss francs ($7.33  billion) in 2006 due to strong sales of cancer treatments  Herceptin and Avastin, just ahead of analysts' expectations.
655985
Pharmaceutical wholesaler McKesson  Corp  reported on Thursday that its quarterly profit  fell 17 percent as results were hurt by lower profit margins on  certain generic drugs and charges taken.
559348
French oil giant Total reports a record 12.58bn euros net profit in 2006 but fourth quarter earnings slip as oil prices fall.